Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature
- PMID: 22543997
- DOI: 10.1007/s00408-012-9389-5
Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature
Abstract
Background: Acute exacerbations (AE) of idiopathic pulmonary fibrosis (IPF) are well recognized in the progression of this uniformly fatal disease. Surgical lung biopsy and lung resection may initiate these acute events leading to a rapid deterioration and permanent decline in lung function. Our aim is to discuss the role of pulmonary and nonpulmonary surgery as a precipitating factor and to review the literature on the nature, course, and outcomes of acute exacerbations in the context of surgical interventions.
Methods: This study consisted of a retrospective case series of patients at the Johns Hopkins Hospital who experienced acute exacerbation following a surgical procedure. Patients included in the case series suffered from aggravation of dyspnea within 1 month after surgical intervention, with new infiltrates on imaging. There was no other more likely cause after diagnostic evaluation. A comprehensive review of the current literature pertaining to AEs of IPF in the context of a surgical intervention was performed.
Results: In a series of four patients from Johns Hopkins Hospital with AE in IPF, two of three patients who underwent video-assisted thoracoscopic surgery (VATS) lung biopsy had a fatal outcome. The fourth patient survived an AE after a total knee replacement but had a fatal outcome after a subsequent coronary artery bypass graft surgery. We found no report in the literature of AE in an IPF patient who underwent nonpulmonary surgery.
Conclusions: Acute exacerbations of IPF can occur postoperatively after both pulmonary and nonpulmonary surgery and are associated with a high mortality rate. As a next step, a prospective multicenter clinical study of patients with IPF undergoing both pulmonary and nonpulmonary surgeries would allow the identification of perioperative risk factors in the development of AE of IPF.
Similar articles
-
Acute exacerbations of idiopathic pulmonary fibrosis.Respiration. 2013;86(4):265-74. doi: 10.1159/000355485. Epub 2013 Oct 19. Respiration. 2013. PMID: 24157720 Review.
-
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).Respir Res. 2016 Jul 22;17(1):90. doi: 10.1186/s12931-016-0398-4. Respir Res. 2016. PMID: 27450274 Free PMC article. Clinical Trial.
-
Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.Respirology. 2016 Nov;21(8):1431-1437. doi: 10.1111/resp.12862. Epub 2016 Jul 26. Respirology. 2016. PMID: 27460223
-
Patterns and Economic Burden of Hospitalizations and Exacerbations Among Patients Diagnosed with Idiopathic Pulmonary Fibrosis.J Manag Care Spec Pharm. 2016 Apr;22(4):414-23. doi: 10.18553/jmcp.2016.22.4.414. J Manag Care Spec Pharm. 2016. PMID: 27023695 Free PMC article.
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis.Medicina (Kaunas). 2019 Mar 16;55(3):70. doi: 10.3390/medicina55030070. Medicina (Kaunas). 2019. PMID: 30884853 Free PMC article. Review.
Cited by
-
Secondary analysis of preoperative predictors for acute postoperative exacerbation in interstitial lung disease.Sci Rep. 2023 Aug 25;13(1):13955. doi: 10.1038/s41598-023-41152-y. Sci Rep. 2023. PMID: 37626100 Free PMC article.
-
Risk factors for mortality and mortality rates in interstitial lung disease patients in the intensive care unit.Eur Respir Rev. 2018 Nov 21;27(150):180061. doi: 10.1183/16000617.0061-2018. Print 2018 Dec 31. Eur Respir Rev. 2018. PMID: 30463873 Free PMC article.
-
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 revision.Respirology. 2024 Feb;29(2):105-135. doi: 10.1111/resp.14656. Epub 2024 Jan 11. Respirology. 2024. PMID: 38211978 Free PMC article.
-
Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Proposal.Curr Respir Care Rep. 2013 Dec;2(4):10.1007/s13665-013-0065-x. doi: 10.1007/s13665-013-0065-x. Curr Respir Care Rep. 2013. PMID: 24416637 Free PMC article.
-
Sevoflurane inhibits cardiac function in pulmonary fibrosis mice through the TLR4 signaling pathway.Pulm Circ. 2018 Oct-Dec;8(4):2045894018800702. doi: 10.1177/2045894018800702. Epub 2018 Aug 30. Pulm Circ. 2018. PMID: 30160595 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials